TGTX   $35.07  1.51% Market Closed After Close 35.5 1.23%

TG Therapeutics Inc
Total Cash 217.25M
totalCashPerShare 1.514
EBITDA -410.00K
Total Debt 112.92M
quickRatio
currentRatio
Total Revenue 264.79M
debtToEquity 63.592
Revenue/Share 1.829
ROA
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth -0.97
revenueGrowth -0.494
grossMargins 0.88315004
ebitdaMargins -0.00155
operatingMargins 0.14824
profitMargins -0.054250002
enterpriseValue 3.61B
forwardPE 30.069767
floatShares 133.47M
sharesOutstanding 154.82M
sharesShort 32.48M
sharesShortPriorMonth 29.84M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.62%
Short Ratio help_outline 7.76%
shortPercentOfFloat 0.23%
impliedSharesOutstanding
bookValue 1.238
Price To Book help_outline 20.89
earningsQuarterlyGrowth -0.97
netIncomeToCommon -14.36M
trailingEps -0.10%
forwardEps 0.86%
enterpriseToEbitda -8.79K
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.08 4Q 2024
institutionsCount 352
lastUpdated Nov. 6, 2024, 5:25 p.m.